---
title: "BioPharma AI Weekly - Issue #19 (2025.05.09)"
date: 2025-05-09
categories: [Weekly News]
published: false
---

# AI Technology Updates

## Wiley Ã— AWS - Open Source AI Agent for Life Sciences
- [Wiley-AWS Agent News](https://www.rdworldonline.com/wiley-teams-with-aws-to-bake-full-text-search-into-life-sciences-ai-agents/)
- AI agent for rapid literature search in life sciences integrated with AWS toolkit.

## Iambic - Enchant v2 Multimodal Model
- Iambic released Enchant v2, a multimodal model outperforming in vitro experiments in select drug property prediction tasks.

# AI in BioPharma

## Recursion - MEK1/2 Inhibitor Clinical Results
- Recursion's AI-designed MEK1/2 inhibitor showed promising results in reducing polyps for FAP patients in early clinical trials.

## Lantern Pharma - Triple Negative Breast Cancer Clinical Trial
- Lantern Pharma began Phase 1b/2 clinical trials for an AI-designed therapy for triple-negative breast cancer after FDA approval.

## Nature Comms Medicine - AI Misses 66% of Severe Hospital Injuries
- ML models missed most critical cases in shifting hospital conditions, cautioning over-reliance on data-driven models alone.

# Conferences & Events

No major conferences or events highlighted this week.
